OptiBiotix Health Plc

LSE:OPTI.L

Sector

🛒 Consumer Staples

Industries

🧬 Biotechnology

🏬 Consumer Packaged Goods

🌱 Organic Foods

🐶 Pet Food

🍟 Snack Foods

Location

United Kingdom

Market Cap

USD 16.00 M

Share Price

USD 0.15

Avg Daily Volume

406,733

Change (1 day)

0.68%

Change (1 year)

-22.42%

Change (YTD)

-31.21%

OptiBiotix Health Plc Market Capitalization on June 24, 2025: USD 16.00 M

OptiBiotix Health Plc Market Capitalization is USD 16.00 M on June 24, 2025, a -14.35% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

OptiBiotix Health Plc 52-week low Market Capitalization is USD 40.28 M on June 24, 2025, which is 151.79% above the current Market Capitalization.
OptiBiotix Health Plc 52-week low Market Capitalization is USD 12.96 M on June 24, 2025, which is -18.96% below the current Market Capitalization.
OptiBiotix Health Plc average Market Capitalization for the last 52 weeks is USD 22.18 M.

Daily

From:

To:

Zoom:

Key data

Date	Market Capitalization	Share Price	Share Price	Price to Earnings Ratio (P/E)

LSE: OPTI.L

OptiBiotix Health Plc

CEO	Mr. Stephen Patrick O'Hara
IPO Date	Sept. 9, 2011
Location	United Kingdom
Headquarters	Innovation Centre
Employees	10
Sector	🛒 Consumer Staples
Industries Biotechnology 🏬 Consumer Packaged Goods 🌱 Organic Foods 🐶 Pet Food 🍟 Snack Foods

Description

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.